Short Interest in Lexaria Bioscience Corp. (NASDAQ:LEXXW) Decreases By 98.1%

Lexaria Bioscience Corp. (NASDAQ:LEXXW) was the recipient of a large drop in short interest in June. As of June 15th, there was short interest totalling 100 shares, a drop of 98.1% from the May 31st total of 5,400 shares. Based on an average daily volume of 15,900 shares, the short-interest ratio is currently 0.0 days.

Lexaria Bioscience Stock Down 34.6 %

NASDAQ LEXXW opened at $0.85 on Friday. The business has a 50 day moving average price of $1.18 and a 200 day moving average price of $0.97. Lexaria Bioscience has a 1-year low of $0.05 and a 1-year high of $2.50.

Lexaria Bioscience Company Profile

Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods.